)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Boule Diagnostics
Boule Diagnostics (BOUL) investor relations material
Boule Diagnostics Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary11 Feb, 2026
Executive summary
Q4 sales declined 16% year-over-year, mainly due to currency headwinds and the transition to licensed manufacturing in India, while OEM sales remained stable and operational improvements led to better profitability and cash flow.
Gross margin improved to 48.1% from 44.6% year-over-year, driven by a favorable product mix and higher reagent sales.
Adjusted EBIT for Q4 was SEK 12.9 million, with a positive operating cash flow of SEK 5.5 million, marking the third consecutive quarter of positive cash flow.
New headquarters in Sweden were inaugurated, consolidating two sites to improve efficiency and strengthen the operational platform for future growth.
Full-year sales were SEK 489.7 million, down organically by 7.2% year-over-year, with significant profitability improvement compared to the prior year.
Financial highlights
Q4 sales were SEK 120.2 million, down 16% year-over-year, with an 11.7% organic decline and a 4.3% negative currency impact.
Q4 gross profit was SEK 57.8 million, down from SEK 63.8 million; gross margin improved to 48.1% from 44.6% year-over-year.
Adjusted EBIT for Q4 was SEK 12.9 million; full-year adjusted EBIT was SEK 46.2 million.
Q4 operating cash flow was SEK 5.5 million, up from SEK -7.9 million last year; available liquidity at year-end was SEK 35 million (SEK 20 million cash, SEK 15 million unused credit facility).
Full-year profit was SEK -3.8 million, a substantial improvement from SEK -296.6 million in 2024.
Outlook and guidance
Structural margin improvements are expected to be repeatable due to manufacturing initiatives and cost control, with continued focus on expanding operating margins through cost reductions and efficiency improvements.
New OEM projects and a veterinary hematology instrument are planned for launch in 2026, with new blood control products launching in 2027.
Renewed and expanded supply agreements are expected to increase annual sales by SEK 5 million from 2027.
Continued headwinds from a strong SEK against the USD are anticipated to impact gross margin in coming quarters.
Investments in digital marketing, lead generation, and portfolio development will continue.
Strategy to reduce net debt and related party loans
Offset instrument sales decline with new products?
Timeline and financial impact of Russia divestment
What are the long-term gains from India transition?
Justify increased OEM OpEx for future growth
Where will further cost base reductions come from?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Boule Diagnostics earnings date
Q1 202628 Apr, 2026
Boule Diagnostics
Next Boule Diagnostics earnings date
Q1 202628 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Boule Diagnostics designs and manufactures instruments and consumables for use in laboratories around the globe to provide fast, accurate blood diagnostics. The company develops new technology platforms that offer improved speed, performance and reliability, broaden range and applicability of tests, and increase automation workflow efficiency through more effective diagnostics.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage